Answers are grounded in this paper and cite their sources.
Background Acute kidney injury (AKI) is a clinically significant syndrome marked by a rapid decline in renal function, with high morbidity and limited effective therapies. The multifactorial pathogenesis of AKI involves oxidative stress, inflammation, and regulated cell death, contributing to a high risk of chronic kidney disease and mortality. Natural products, with their multitarget potential, offer promising avenues for nephroprotection, but require rigorous chemical and mechanistic validation. Aim This study evaluated the nephroprotective potential of a chemically profiled ethanolic leaf extract of Baliospermum solanifolium by integrating untargeted metabolomic profiling and systems pharmacology with in vivo assessment in cisplatin-induced acute kidney injury and repeated mercuric chloride-induced nephrotoxicity. Methods Fresh B. solanifolium leaves were extracted with ethanol, followed by untargeted UHPLC–Orbitrap MS/MS profiling, chemical classification, and in silico pharmacokinetic and drug-likeness prioritization. Network pharmacology and computational target prediction were integrated with AKI-associated gene sets to identify overlapping targets and pathways. Hub targets were prioritized for molecular docking and 200 ns molecular dynamics simulations. The extract was evaluated in cisplatin-induced AKI and repeated mercuric chloride-induced nephrotoxicity using serum renal-function indices and qualitative histopathology. Results UHPLC–Orbitrap MS/MS annotation identified 525 putative metabolites, 66 of which were prioritized for pharmacological analysis. Network and module analyses revealed key overlaps with inflammatory, survival, hypoxic, and cell-death pathways. HSP90AA1, STAT3, ESR1, and MAPK1 were prioritized for structure-based studies, and molecular docking plus MD simulations supported target-specific binding hypotheses for selected phytocompounds. In vivo , the extract produced numerical improvements across the administered dose levels in body weight and serum renal-function indices across both experimental paradigms, together with qualitative histomorphological improvement, particularly at higher doses. Conclusion The ethanolic leaf extract of B. solanifolium showed biochemical evidence consistent with preventive renal protection in cisplatin-induced AKI and repeated mercuric chloride-induced nephrotoxicity. The study supports a chemically anchored, hypothesis-generating multitarget framework integrating high-resolution metabolomics, systems pharmacology and in vivo pharmacological evaluation. These findings provide a basis for future mechanistic and translational validation.
No takes yet. Share an insight, caveat, or question.
Rajesh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: